Update on measurement of relevant outcomes in rheumatology

Current Opinion in Rheumatology

Volumn 8, Issue 2, 1996, Pages 101-105

  Pioro, Mathilde H ^a   Kwoh, C Kent ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DISEASE ACTIVITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MORTALITY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHEUMATIC DISEASE; SOCIOECONOMICS; TREATMENT OUTCOME; WORK;

EID: 0029879775     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199603000-00003     Document Type: Review

References (35)

1. Ellwood P: Shattuck lecture. Outcomes management: a technology of patient experience. N Engl J Med 1988, 318:1549-1556.
2. Fries J: Toward an understanding of patient outcome measurement Arthritis Rheum 1983, 26:697-704.
3. Wolfe F: Health status questionnaires. Rheum Dis Clin North Am 1995, 21:445-464. An updated review of health status questionnaires used in rheumatology.
4. Long A, Scott D: Measuring health status and outcomes in rheumatoid arthritis within routine clinical practice. Br J Rheumatol 1994, 33:682-685.
5. Bruhlmann P, Stucki G, Michel B: Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. J Rheumatol 1994, 21:1245-1249.
6. Gonzalez V, Stewart A, Ritter P, Lorig K: Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 1995, 38:1429-1446.
7. Redelmeier D, Lorig K: Assessing the clinical importance of symptomatic improvements: an illustration in rheumatology. Arch Intern Med 1993, 153:1337-1342.
8. Bellamy N: Outcome measurement in osteoarthritis clinical trials. J Rheumatol 1995, 22(suppl 43):49-51. A concise review of disease-specific instruments (eg, Western Ontario and McMaster University osteoarthritis index, Lequesne index) and generic instruments (eg, short form 36) for outcomes measurement in osteoarthritis.
9. Beard C, Lane A, O'Fallon W, Riggs B, Melton L: Comparison of respondents and nonrespondents in an osteoporosis study. Ann Epidemiol 1994, 4:396-403.
10. Clarke A, Bloch D, Medsger TJ, Oddis C: A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 1995, 38:1218-1224.
11. Luqmani R, Bacon P, Moots RJ, Jans/sen BA, Pall A, Emery P, Savage C, Ado D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994, 87:671-678.
12. Abushakra M, Smythe H, Lewtas H, Badley E, Weber D, Keystone E: Outcome of polyarteritis nodosa and Churg-Strauss syndrome: an analysis of twenty-five patients. Arthritis Rheum 1994, 37:1798-1803. The authors introduce a new damage index for quantification of disease activity and damage in vasculitis.
13. Massardo L, Martinez M, Jacobelli S, Villarroel L, Rosenberg H, Rivero S: Survival of Chilean patients with systemic lupus erythematous. Semin Arthritis Rheum 1994, 24:1-11.
14. Visuri T PP, Turula KB, Paavolainen P, Koskenvuo M: Life expectancy after hip arthroplasty: case-control study of 1018 cases of primary arthrosis. Acta Orthop Scand 1994, 65:9-11. In this large Scandinavian population, life expectancy in patients 10 years after hip arthroplasty was the same as that of othopedic controls and better than that of the general population.
15. Ward M, Pyun E, Studenski S: Long-term survival in systemic lupus erythematosus: patient characteristics associated with poorer outcomes. Arthritis Rheum 1995, 38:274-283.
16. Gorgos L, Goldman D, Petri M: The ACR/SLICC damage index in systemic lupus erythematosus. Arthritis Rheum 1993, 36(suppl 9):68.
17. Petri M: Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: an update. Arthritis Care Res 1995, 8:137-144. The authors describe muscloskeletal damage in their large cohort of systemic lupus erythematosus patients using the SLICC/ACR index, which quantifies cumulative damage from disease as well as ongoing disease activity. Corticosteroid-related complications were found to be a major cause of morbidity.
18. Katz S FA, Moskowitz RW, Jackson AB, Jaffe MA: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1965, 185:914-919.
19. Egger M, Ward J, Karg M, Williams H, Reading J: Reliability and validity of the CSSRD functional assessment survey in rheumatoid arthritis. Arthritis Care Res 1995, 8:21-27.
20. Vanschaardenberg D, Vandenbrande K, Ligthart G, Breedveld F, Hazes J: Musculoskeletal disorders and disability in persons aged 85 and over: a community survey. Ann Rheum Dis 1994, 53:807-811. A well-designed cross-sectional study showing that in elderly, mostly independent persons, other medical disorders were at least as important as osteoarthritis in the development of disability.
21. Erhardt C: Evaluation of treatment and outcome in rheumatic disease. J R Soc Med 1994, 87:641-643. Highlights of a discussion of outcomes measurement by M.H. Liang.
22. Badley E: The effect of osteoarthritis on disability and health care use in Canada. J Rheumatol 1995, 22(suppl 43):19-22. A review of the impact of osteoarthritis on the Canadian population, based on 1987-1990 household interview data.
23. Yelin E, Callahan L: The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995, 38:1351-1362. An extensive review of the 1990-1992 NHIS data and review of the literature.
24. Eberhardt K LB, Nived K: Early rheumatoid arthritis: some social, economic, and psychological aspects. Scand J Rheumatol 1993, 22:119-123.
25. World Health Organization: The Ten Years of the World Health Organization. Geneva: World Health Organization; 1958.
26. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 1994, 272:619-626.
27. Guyatt G, Cook D: Health status, quality of life, and the individual. JAMA 1994, 272:630-631.
28. Kirwan JR, Freeman MAR, Young PJ: Overall long-term impact of total hip and knee joint replacement surgery on patients with osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1994, 33:357-360.
29. Martinez J, Ferraz M, Sato E, Atra E: Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol 1995, 22:270-274.
30. Prashker M: Health care research and policy studies. Curr Opin Rheumatol 1995, 7:92-96.
31. Ferraz M, Quaresma M, Goldsmith C, Bennett K, Atra E: Estimation of benefits and risks of the treatment of rheumatoid polyarthritis with glucocorticoids using the health-related quality of life measurements [in French]. Rev Rhum 1994, 61:255-259.
32. Ward M, Leigh J: The relative importance of pain and functional disability to patients with rheumatoid arthritis. J Rheumatol 1993, 20:1494-1499.
33. Aharony L SS: Patient satisfaction: what we know about and what we still need to explore. Med Care Rev 1993, 50:49-79.
34. Arthritis prevalence and activity limitations: United States. JAMA 1994, 272:346-347. Reprint of an article from the Morbidity and Mortality Weekly Report summarizing 1991 NHIS data. Arthritis was reported as a major or contributing cause of activity limitation by 2.8% of Americans.
35. Reisine S, Fifield J: Health insurance problems among insured rheumatoid arthritis patients. Arthritis Care Res 1995, 8:155-160. Results of a survey of a national sample of rheumatoid arthritis patients concerning insurance coverage, preexisting condition clauses, and the financial impact of arthritis.